Browsing by Author "Moreno, Mireia"

Sort by: Order: Results:

  • Dual targeted therapy in patients with psoriatic arthritis and spondyloarthritis: a real-world multicenter experience from Spain
    Valero-Martínez, Cristina; Font Urgelles, Judit; Sallés, Meritxell; Joven-Ibáñez, Beatriz E.; Juanes, Alexia de; Ramírez, Julio; Juanola, Xavier; Almodóvar, Raquel; Laiz, Ana; Moreno, Mireia; Pujol, Manel; Beltrán, Emma; Pinto-Tasende, José Antonio; Crespí, Laura; Sala-Icardo, Luis; Castañeda, Santos; García-Vicuna, Rosario (Frontiers, 2023)
    Dual targeted therapy (DTT) has emerged as a promising approach in patients with refractory spondyloarthritis (SpA) or psoriatic arthritis (PsA) and extra-musculoskeletal manifestations of both diseases, but its ...
  • Increased plasma levels of galectin-1 in pancreatic cancer: potential use as biomarker
    Martínez Bosch, Neus; Barranco Priego, Luis Eugenio; Orozco, Carlos Alberto; Moreno, Mireia; Visa Turmo, Laura; Iglesias Coma, Mar; Oldfield, Lucy; Neoptolemos, John; Greenhalf, William; Earl, Julie; Carrato, Alfredo; Costello, Eithne; Navarro Medrano, Pilar (Impact Journal, 2018)
    Pancreatic ductal adenocarcinoma (PDA) is the most frequent type of pancreatic cancer and one of the deadliest diseases overall. New biomarkers are urgently needed to allow early diagnosis, one of the only factors that ...
  • Sialyltransferase inhibitor Ac53FaxNeu5Ac reverts the malignant phenotype of pancreatic cancer cells, and reduces tumor volume and favors T-cell infiltrates in mice
    Miró, Laura; López, Júlia; Guerrero, Pedro E.; Martínez Bosch, Neus; Manero Rupérez, Noemí; Moreno, Mireia; Ortiz, María Rosa; Llop Escorihuela, Esther; Navarro Medrano, Pilar; Peracaula, Rosa (MDPI, 2022)
    Hypersialylation is a feature of pancreatic ductal adenocarcinoma (PDA) and it has been related to tumor malignancy and immune suppression. In this work, we have evaluated the potential of the sialyltransferase inhibitor, ...
  • Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis
    Martínez Bosch, Neus; Cristóbal, Helena; Iglesias Coma, Mar; Gironella, Meritxell; Barranco Priego, Luis Eugenio; Visa Turmo, Laura; Calafato, Domenico; Jiménez-Parrado, Silvia; Earl, Julie; Carrato, Alfredo; Manero Rupérez, Noemí; Moreno, Mireia; Morales, Albert; Guerra, Carmen; Navarro Medrano, Pilar; García de Frutos, Pablo (Elsevier, 2022)
    Background: Early diagnosis is crucial for patients with pancreatic ductal adenocarcinoma (PDAC). The AXL receptor tyrosine kinase is proteolytically processed releasing a soluble form (sAXL) into the blood stream. Here ...
  • Sustained low disease activity measured by ASDAS slow radiographic spinal progression in axial spondyloarthritis patients treated with TNF-inhibitors: data from REGISPONSERBIO
    Llop, Maria; Moreno, Mireia; Navarro-Compán, Victoria; Juanola, Xavier; Miguel, Eugenio de; Almodóvar, Raquel; Cuende Quintana, Eduardo; Sanz Sanz, Jesús; Beltrán, Emma; Ruiz Montesinos, M. Dolores; Calvet, Joan; Berenguer-Llergo, Antonio; Gratacós, Jordi; Regisponserbio group (BioMed Central, 2022)
    Background: To evaluate the influence of the disease activity on radiographic progression in axial spondyloarthritis (axSpA) patients treated with TNF inhibitors (TNFi). Methods: The study included 101 axSpA patients from ...
  • Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk
    Orozco, Carlos Alberto; Martínez Bosch, Neus; Enrique Guerrero, Pedro; Vinaixa Forner, Judith, 1991-; Dalotto-Moreno, Tomás; Iglesias García, Mar; Moreno, Mireia; Djurec, Magdolna; Poirier, Françoise; Gabius, Hans J.; Fernández-Zapico, Martin E.; Hwang, Rosa F.; Guerra, Carmen; Rabinovich, Gabriel A.; Navarro Medrano, Pilar (National Academy of Sciences, 2018)
    Pancreatic ductal adenocarcinoma (PDA) remains one of the most lethal tumor types, with extremely low survival rates due to late diagnosis and resistance to standard therapies. A more comprehensive understanding of the ...
  • The pancreatic niche inhibits the effectiveness of sunitinib treatment of pancreatic cancer.
    Martínez Bosch, Neus; Enrique Guerrero, Pedro; Moreno, Mireia; José Segarra-Martínez, Anabel; Iglesias García, Mar; Munné-Collado, Jessica; Anta Rodríguez, Héctor, 1988-; Gibert, Joan; Orozco, Carlos Alberto; Vinaixa Forner, Judith, 1991-; Fillat i Fonts, Cristina; Viñals, Francesc; Navarro Medrano, Pilar (Impact Journals, 2016)
    Current treatments for pancreatic ductal adenocarcinoma (PDA) are ineffective, making this the 4th leading cause of cancer deaths. Sunitinib is a broad-spectrum inhibitor of tyrosine kinase receptors mostly known for its ...
  • Ultrasound assessment of psoriatic onychopathy: a cross-sectional study comparing psoriatic onychopathy with onychomycosis
    Moreno, Mireia; Lisbona Pérez, María Pilar; Gallardo Hernández, Fernando; Deza Vargas, Luis Gustavo; Ferran Farrés, Marta; Pontes, Caridad; Luelmo, Jesús; Maymó Guarch, Joan; Gratacós, Jordi (Society for Publication of Acta Dermato-Venereologica, 2019)
    This cross-sectional study evaluated the usefulness of an ultrasound technique in assessment of nail changes in 35 patients with psoriatic onychopathy and 25 with nail dystrophy secondary to onychomycosis. All patients ...

Search DSpace

Browse

My Account

In collaboration with Compliant to Partaking